SCHEMBL6445182

SCHEMBL6445182

CCc1nc2cc(C(N)=O)ccc2n1-c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.59
KMT2A Q03164 2/20 0.55
JAK2 O60674 6/20 0.53
JAK1 P23458 6/20 0.53
TYK2 P29597 6/20 0.53
JAK3 P52333 6/20 0.53
SIRT2 Q8IXJ6 2/20 0.53
SIRT1 Q96EB6 2/20 0.53
FGFR1 P11362 1/20 0.52
PTGER4 P35408 1/20 0.52
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
PABPC1 P11940 1/20 0.47
PDE10A Q9Y233 1/20 0.46
CRBN Q96SW2 1/20 0.46
MGLL Q99685 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22470796 0.90 ACSS2 (0.52) HSD17B10KMT2AJAK2JAK1TYK2
SCHEMBL5317401 0.90 HSD17B10 (0.73) HSD17B10KMT2ASIRT2SIRT1FGFR1
SCHEMBL1623811 0.84 JAK2 (0.56) HSD17B10KMT2AJAK2JAK1TYK2
SCHEMBL27599850 0.84 TP53 (0.55) HSD17B10KMT2AJAK2JAK1TYK2
SCHEMBL1625910 0.84 KMT2A (0.50) HSD17B10KMT2AJAK2JAK1TYK2
SCHEMBL1625941 0.83 KMT2A (0.49) HSD17B10KMT2AJAK2JAK1TYK2
SCHEMBL5809308 0.81 FGFR1 (0.57) HSD17B10KMT2AJAK2JAK1TYK2
SCHEMBL30832791 0.79 KMT2A (0.50) HSD17B10KMT2AJAK2JAK1TYK2
SCHEMBL25112562 0.79 PDE10A (0.63) SIRT2SIRT1FGFR1PDE10AALDH1A1
SCHEMBL27582731 0.79 TP53 (0.45) HSD17B10KMT2AJAK2JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499305-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES Pfizer Japan Inc. (JP) 2005-01-26 EP disclosed
WO-2003086371-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES PFIZER JAPAN INC. (JP) 2003-10-23 WO disclosed